Downregulation of the tumour suppressive Hippo pathway leading to YAP/TAZ activation, RUNX2 stabilisation [224] and TEAD transcription factor onset is a key target in several cancers [225, 226] including Ewing sarcoma. This evidence concerns the gene YAP1 and Ewing sarcoma.